Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database.

LD imposes a substantial burden on affected individuals due to a high prevalence of metabolic comorbidities and other complications as compared with the general non-LD population. Future longitudinal follow-up studies investigating the causality between LD and observed comorbidities are warranted.